 T, Birkeland K, Rustoen T.
A comparison of the health-related quality of life in patients with
diabetic foot ulcers, with a diabetes group and a nondiabetes
group from the general population. Qual Life Res 2007;16:179-89.

133. A randomised, blinded, trial of clopidogrel versus aspirin in patients
at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.
Lancet 1996;348:1329-39.
134. Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention
of cardiovascular events in patients with peripheral artery disease: a
meta-analysis of randomized trials. JAMA 2009;301:1909-19.
135. Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ.
Ampliﬁed beneﬁt of clopidogrel versus aspirin in patients with
diabetes mellitus. Am J Cardiol 2002;90:625-8.
136. Anand SS, Caron F, Eikelboom JW, Bosch J, Dyal L, Aboyans V,
et al. Major adverse limb events and mortality in patients with
peripheral artery disease: the COMPASS Trial. J Am Coll Cardiol
2018;71:2306-15.
137. Twine CP, Kakkos SK, Aboyans V, Baumgartner I, Behrendt C-A,
Bellmunt-Montoya S, et al. European Society for Vascular Surgery
(ESVS) 2023 Clinical Practice Guidelines on Antithrombotic Therapy
for Vascular Diseases. Eur J Vasc Endovasc Surg 2023;65:627-89.
138. Bosch J, Eikelboom JW, Connolly SJ, Bruns NC, Lanius V, Yuan F,
et al. Rationale, design and baseline characteristics of participants
in the cardiovascular outcomes for people using anticoagulation
strategies (COMPASS) trial. Can J Cardiol 